SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MYGN
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
29 7 0 MYGN
Emcee:  pat w. Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
29Myriad Genetics Presents Results of Phase 2 Trial of Flurizan(TM) in Patients Wibob zagorin-6/20/2005
28You were quick! I realised my mistake and corrected it, but you beat me too it.A.J. Mullen-5/4/2005
27huh? that reads mygn to me.....bob zagorin-5/4/2005
26Bob, the discussion on Mygn has moved: Subject 7427A.J. Mullen-5/4/2005
25Myriad Plans More Flurizan Tests By Robert Steyer TheStreet.com Staff Reporter 5bob zagorin-5/2/2005
24There have been downgrades from CSFB and Bear Stearns based primarily on the redA.J. Mullen-8/28/2003
23Myriad Genetics Reports Financial Results for Fiscal 2003 Tuesday, August 26, A.J. Mullen-8/28/2003
22 Earnings Release. I am surprised there hasn't been more reaction in price.A.J. Mullen-11/11/1999
21 Today's recommendation that Tamoxifen be approved as a prophylactive for woA.J. Mullen-9/3/1998
20 Does anyone know what this stock has not moved in the past week? What is goingKristina Boydd-5/27/1998
19 What is ProNet? Thanks; Steve Steve Lokness-5/22/1998
18 Is there nobody who is concerned about competition and legal aspects about possRoland Ott-4/13/1998
17 A.J., You bring up some good points. Patient privacy will be a touchy issue gLee Allgood-4/12/1998
16 I've been typing to myself for sometime on "Myriad Genetics." GlA.J. Mullen-4/11/1998
15 Yes, and I am in for the long haul. This is an extremely undervalued biotech. Lee Allgood-4/9/1998
14 from Briefing.com: Myriad Genetics Inc. (MYGN) 20 1/2 +3/8: Lehman Brothers thRoger Steiner-4/7/1998
13 Please note that 290,000 shares is approx 5% of the floatLee Allgood-2/24/1998
12 290,000 shares traded right at 3:00 p.m. today. Somebody's highly interestLee Allgood-2/23/1998
11 In recent issue of Forbes (week before last, I think), Michael Gianturco (sp) rJohn Prugh-2/21/1998
10 Oliver..yes. I did notice the downgrade. It came form Cowen and Co. on FeburaryIsrael-2/20/1998
9 Issue has been downgraded by a Wall St broker from "strong buy" to &qOliver Ruppert-2/20/1998
8 I believe MYGN is much undervalued at the present moment. I think it will recovRoland Ott-2/20/1998
7 WoW...no posts in almost 3 months... Everyone too busy getting rich off the DOWIsrael-2/20/1998
6 Upgrade from Lehman Brothers to "strong buy" (from outperform) !Oliver Ruppert-11/20/1997
5 Come one, everybody WAKE UP ! Here's an anouncement and people expect them Oliver Ruppert-11/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News